{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:02:09Z","timestamp":1778846529191,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T00:00:00Z","timestamp":1313884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00432-011-1032-y","type":"journal-article","created":{"date-parts":[[2011,8,20]],"date-time":"2011-08-20T10:50:50Z","timestamp":1313837450000},"page":"1619-1627","source":"Crossref","is-referenced-by-count":11,"title":["Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors"],"prefix":"10.1007","volume":"137","author":[{"given":"Thierry","family":"Marysael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yicheng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Lerut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,21]]},"reference":[{"issue":"16","key":"1032_CR1","first-page":"4578","volume":"49","author":"FM Chen","year":"1989","unstructured":"Chen FM, Taylor CR, Epstein AL (1989) Tumor necrosis treatment of ME-180 human cervical carcinoma model with 131I-labeled TNT-1 monoclonal antibody. Cancer Res 49(16):4578\u20134585","journal-title":"Cancer Res"},{"issue":"2","key":"1032_CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ijc.1324","volume":"93","author":"B Chen","year":"2001","unstructured":"Chen B, Xu Y, Roskams T, Delaey E, Agostinis P, Vandenheede JR, de Witte P (2001) Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 93(2):275\u2013282. doi: 10.1002\/ijc.1324","journal-title":"Int J Cancer"},{"issue":"4","key":"1032_CR4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/sj.bjc.6601606","volume":"90","author":"LM Ching","year":"2004","unstructured":"Ching LM, Zwain S, Baguley BC (2004) Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice. Br J Cancer 90(4):906\u2013910. doi: 10.1038\/sj.bjc.6601606","journal-title":"Br J Cancer"},{"key":"1032_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0065-230X(08)60971-9","volume":"21","author":"EH Cooper","year":"1975","unstructured":"Cooper EH, Bedford AJ, Kenny TE (1975) Cell death in normal and malignant tissues. Adv Cancer Res 21:59\u2013120","journal-title":"Adv Cancer Res"},{"issue":"20","key":"1032_CR6","first-page":"5842","volume":"48","author":"AL Epstein","year":"1988","unstructured":"Epstein AL, Chen FM, Taylor CR (1988) A novel method for the detection of necrotic lesions in human cancers. Cancer Res 48(20):5842\u20135848","journal-title":"Cancer Res"},{"issue":"3","key":"1032_CR7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00810594","volume":"124","author":"H Falk","year":"1993","unstructured":"Falk H, Meyer J, Oberreiter M (1993) A convenient semisynthetic route to hypericin. Monatshefte Fur Chemie 124(3):339\u2013341","journal-title":"Monatshefte Fur Chemie"},{"issue":"7","key":"1032_CR8","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1172\/JCI119336","volume":"99","author":"S Finotto","year":"1997","unstructured":"Finotto S, Mekori YA, Metcalfe DD (1997) Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J Clin Invest 99(7):1721\u20131728. doi: 10.1172\/JCI119336","journal-title":"J Clin Invest"},{"issue":"2","key":"1032_CR9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/eurheartj\/ehm588","volume":"29","author":"H Fonge","year":"2008","unstructured":"Fonge H, Vunckx K, Wang H, Feng Y, Mortelmans L, Nuyts J, Bormans G, Verbruggen A, Ni Y (2008) Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I] iodohypericin microSPECT. Eur Heart J 29(2):260\u2013269. doi: 10.1093\/eurheartj\/ehm588","journal-title":"Eur Heart J"},{"issue":"6","key":"1032_CR10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1517\/14712598.2011.579097","volume":"11","author":"A Hdeib","year":"2011","unstructured":"Hdeib A, Sloan AE (2011) Convection-enhanced delivery of [131I]-chTNT-1\/B mAB for treatment of high-grade adult gliomas. Expert Opin Biol Ther 11(6):799\u2013806. doi: 10.1517\/14712598.2011.579097","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"1032_CR11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0360-3016(03)00769-7","volume":"57","author":"MR Horsman","year":"2003","unstructured":"Horsman MR, Murata R (2003) Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response. Int J Radiat Oncol Biol Phys 57(4):1047\u20131055. doi: 10.1016\/S0360-3016(03)00769-7","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"24","key":"1032_CR12","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1158\/0008-5472.CAN-06-2848","volume":"66","author":"MR Horsman","year":"2006","unstructured":"Horsman MR, Siemann DW (2006) Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies. Cancer Res 66(24):11520\u201311539. doi: 10.1158\/0008-5472.CAN-06-2848","journal-title":"Cancer Res"},{"issue":"5","key":"1032_CR13","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/1078-0432.CCR-06-2436","volume":"13","author":"M Jain","year":"2007","unstructured":"Jain M, Venkatraman G, Batra SK (2007) Optimization of radio immunotherapy of solid tumors: biological impediments and their modulation. Clin Cancer Res 13(5):1374\u20131382. doi: 1078-0432.CCR-06-2436","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1032_CR14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2613.2009.00651.x","volume":"90","author":"C Kanthou","year":"2009","unstructured":"Kanthou C, Tozer GM (2009) Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies. Int J Exp Pathol 90(3):284\u2013294. doi: 10.1111\/j.1365-2613.2009.00651.x","journal-title":"Int J Exp Pathol"},{"issue":"10","key":"1032_CR15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/01.LAB.0000032545.96931.B8","volume":"82","author":"S Koljenovic","year":"2002","unstructured":"Koljenovic S, Choo-Smith LP, Bakker Schut TC, Kros JM, van den Berge HJ, Puppels GJ (2002) Discriminating vital tumor from necrotic tissue in human glioblastoma tissue samples by Raman spectroscopy. Lab Invest 82(10):1265\u20131277","journal-title":"Lab Invest"},{"key":"1032_CR16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1148\/radiol.11102120","volume":"260","author":"J Li","year":"2011","unstructured":"Li J, Sun Z, Zhang J, Shao H, Miranda Cona M, Wang H, Marysael T, Chen F, Prinsen K, Zhou L, Huang D, Nuyts J, Yu J, Meng B, Bormans G, Fang Z, de Witte P, Li Y, Verbruggen A, Wang X, Mortelmans L, Xu K, Marchal G, Ni Y (2011) A dual-targeting anticancer approach: soil and seed principle. Radiology 260:799\u2013807. doi: radiol.11102120","journal-title":"Radiology"},{"issue":"8","key":"1032_CR17","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/cncr.24975","volume":"116","author":"MJ McKeage","year":"2010","unstructured":"McKeage MJ, Baguley BC (2010) Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer. Cancer 116(8):1859\u20131871. doi: 10.1002\/cncr.24975","journal-title":"Cancer"},{"issue":"3\u20134","key":"1032_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.vetpar.2007.08.017","volume":"149","author":"TA Miller","year":"2007","unstructured":"Miller TA, Schaefer FW III (2007) Changes in mouse circulating leukocyte numbers in C57BL\/6 mice immunosuppressed with dexamethasone for Cryptosporidium parvum oocyst production. Vet Parasitol 149(3\u20134):147\u2013157. doi: 10.1016\/j.vetpar.2007.08.017","journal-title":"Vet Parasitol"},{"issue":"3","key":"1032_CR19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0738-081X(99)00128-5","volume":"18","author":"Y Miyachi","year":"2000","unstructured":"Miyachi Y (2000) Pharmacologic modulation of neutrophil functions. Clin Dermatol 18(3):369\u2013373","journal-title":"Clin Dermatol"},{"issue":"8","key":"1032_CR20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/01.rli.0000171811.48991.5a","volume":"40","author":"Y Ni","year":"2005","unstructured":"Ni Y, Bormans G, Chen F, Verbruggen A, Marchal G (2005) Necrosis avid contrast agents: functional similarity versus structural diversity. Invest Radiol 40(8):526\u2013535","journal-title":"Invest Radiol"},{"issue":"5","key":"1032_CR21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00259-005-0013-2","volume":"33","author":"Y Ni","year":"2006","unstructured":"Ni Y, Huyghe D, Verbeke K, de Witte PA, Nuyts J, Mortelmans L, Chen F, Marchal G, Verbruggen AM, Bormans GM (2006) First preclinical evaluation of mono-[123I] iodohypericin as a necrosis-avid tracer agent. Eur J Nucl Med Mol Imaging 33(5):595\u2013601. doi: 10.1007\/s00259-005-0013-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"1032_CR22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2967\/jnumed.110.086116","volume":"52","author":"S Song","year":"2011","unstructured":"Song S, Xiong C, Zhou M, Lu W, Huang Q, Ku G, Zhao J, Flores LG Jr, Ni Y, Li C (2011) Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin. J Nucl Med 52(5):792\u2013799. doi: jnumed.110.086116","journal-title":"J Nucl Med"},{"issue":"6","key":"1032_CR23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1628","volume":"5","author":"GM Tozer","year":"2005","unstructured":"Tozer GM, Kanthou C, Baguley BC (2005) Disrupting tumour blood vessels. Nat Rev Cancer 5(6):423\u2013435. doi: 10.1038\/nrc1628","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"1032_CR24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/sj.bjc.6602512","volume":"92","author":"M Putte Van de","year":"2005","unstructured":"Van de Putte M, Roskams T, Vandenheede JR, Agostinis P, de Witte PA (2005) Elucidation of the tumoritropic principle of hypericin. Br J Cancer 92(8):1406\u20131413. doi: 10.1038\/sj.bjc.6602512","journal-title":"Br J Cancer"},{"issue":"4","key":"1032_CR25","first-page":"921","volume":"19","author":"M Putte Van de","year":"2008","unstructured":"Van de Putte M, Ni Y, De Witte PA (2008a) Exploration of the mechanism underlying the tumor necrosis avidity of hypericin. Oncol Rep 19(4):921\u2013926","journal-title":"Oncol Rep"},{"issue":"1","key":"1032_CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.acra.2007.08.008","volume":"15","author":"M Putte Van de","year":"2008","unstructured":"Van de Putte M, Wang H, Chen F, de Witte PA, Ni Y (2008b) Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model. Acad Radiol 15(1):107\u2013113. doi: 10.1016\/j.acra.2007.08.008","journal-title":"Acad Radiol"},{"issue":"4","key":"1032_CR27","first-page":"927","volume":"19","author":"M Putte Van de","year":"2008","unstructured":"Van de Putte M, Wang H, Chen F, De Witte PA, Ni Y (2008c) Hypericin as a marker for determination of tissue viability after radiofrequency ablation in a murine liver tumor model. Oncol Rep 19(4):927\u2013932","journal-title":"Oncol Rep"},{"issue":"5","key":"1032_CR28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00262-007-0406-0","volume":"57","author":"H Wang","year":"2008","unstructured":"Wang H, Cao C, Li B, Chen S, Yin J, Shi J, Ye D, Tao Q, Hu P, Epstein A, Ju D (2008) Immunogenicity of iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients. Cancer Immunol Immunother 57(5):677\u2013684. doi: 10.1007\/s00262-007-0406-0","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"1032_CR29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1593\/neo.09506","volume":"11","author":"LC Wang","year":"2009","unstructured":"Wang LC, Thomsen L, Sutherland R, Reddy CB, Tijono SM, Chen CJ, Angel CE, Dunbar PR, Ching LM (2009) Neutrophil influx and chemokine production during the early phases of the antitumor response to the vascular disrupting agent DMXAA (ASA404). Neoplasia 11(8):793\u2013803","journal-title":"Neoplasia"},{"issue":"8","key":"1032_CR30","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00330-010-1743-5","volume":"20","author":"H Wang","year":"2010","unstructured":"Wang H, Li J, Chen F, De Keyzer F, Yu J, Feng Y, Nuyts J, Marchal G, Ni Y (2010) Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours. Eur Radiol 20(8):2013\u20132026. doi: 10.1007\/s00330-010-1743-5","journal-title":"Eur Radiol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-011-1032-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1032-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:40:03Z","timestamp":1559083203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-011-1032-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,21]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1032"],"URL":"https:\/\/doi.org\/10.1007\/s00432-011-1032-y","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,21]]}}}